International Journal of Cardiology
Volume 112, Issue 2 , Pages 229-233 , 20 September 2006

Blood rheological properties are strongly related to the metabolic syndrome in middle-aged Chinese

Received 19 August 2005 ,Revised 26 October 2005 ,Accepted 17 November 2005.

References 

  1. Woodward M, Rumley A, Tunstall-Pedoe H, Lowe GD. Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol. 1999;104:246–257
  2. Lowe GD, Lee AJ, Rumley A, Price JF, Fowkes FG. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol. 1997;96:168–173
  3. Kensey KR. The mechanistic relationships between hemorheological characteristics and cardiovascular disease. Curr Med Res Opin. 2003;19:587–596
  4. Devereux RB, Case DB, Alderman MH, Pickering TG, Chien S, Laragh JH. Possible role of increased blood viscosity in the hemodynamics of systemic hypertension. Am J Cardiol. 2000;85:1265–1268
  5. Sloop GD, Garber DW. The effects of low-density lipoprotein and high-density lipoprotein on blood viscosity correlate with their association with risk of atherosclerosis in humans. Clin Sci. 1997;92:473–479
  6. Diamantopoulos EJ, Kittas C, Charitos D, Grigoriadou M, Ifanti G, Raptis SA. Impaired erythrocyte deformability precedes vascular changes in experimental diabetes mellitus. Horm Metab Res. 2004;36:142–147
  7. Brun JF, Aloulou I, Varlet-Marie E. Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia?. Clin Hemorheol Microcirc. 2004;30:203–209
  8. Wang YY, Lin SY, Liu PH, Cheung BM, Lai WA. Association between hematological parameters and metabolic syndrome components in a Chinese population. J Diabetes Complications. 2004;18:322–327
  9. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
  10. Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108:414–419
  11. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation. 2003;107:391–397
  12. Tous M, Ferre N, Vilella E, Riu F, Camps J, Joven J. Circulating blood cells modulate the atherosclerotic process in apolipoprotein E-deficient mice. Metabolism. 2004;53:95–100
  13. Abendroth D, Landgraf R, Pfeiffer M, Reininger J, Seidel D, Land W. Long-term follow-up of lipid metabolism and rheologic properties after successful pancreas and kidney transplantation. Transpl Int. 1994;7:S417–S419
  14. Os I, Hoieggen A, Larsen A, et al. Smoking and relation to other risk factors in postmenopausal women with coronary artery disease, with particular reference to whole blood viscosity and beta-cell function. J Intern Med. 2003;253:232–239
  15. Valensi P, Paries J, Maheo P, Gaudey F, Attali JR. Erythrocyte rheological changes in obese patients: influence of hyperinsulinism. Int J Obes Relat Metab Disord. 1996;20:814–819
  16. Nasser JA, Hashim SA, Lachance PA. Calcium and magnesium ATPase activities in women with varying BMIs. Obes Res. 2004;12:1844–1850
  17. Chunyi W, Yanjun Z, Weibo K. The influence of calcium ions and ionophore A23187 on microrheological characteristics of erythrocytes by new model ektacytometry. Clin Hemorheol Microcirc. 2001;24:19–23
  18. Bogar L. Hemorheology and hypertension: not “chicken or egg” but two chickens from similar eggs. Clin Hemorheol Microcirc. 2002;26:81–83
  19. Babu N, Singh M. Analysis of aggregation parameters of erythrocytes in diabetes mellitus. Clin Hemorheol Microcirc. 2005;32:269–277
  20. de Simone G, Devereux RB, Chinali M, Best LG, Lee ET, Welty TK, et al. Association of blood pressure with blood viscosity in American Indians: the strong heart study. Hypertension. 2005;45:625–630
  21. Ferretti G, Bacchetti T, Busni D, Rabini RA, Curatola G. Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients. J Clin Endocrinol Metab. 2004;89:2957–2962
  22. Guo J, Zhang L, Jiang Y, et al. Effects of compound dan-shen root dropping pill on hemorheology in high-fat diet induced hyperlipidemia in dogs. Clin Hemorheol Microcirc. 2005;32:19–30
  23. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in type 2 diabetic men with and without coronary heart disease. Diabetologia. 2004;47:1557–1565
  24. Liu X, Qin W, Yin D. Biochemical relevance between oxidative/carbonyl stress and elevated viscosity of erythrocyte suspensions. Clin Hemorheol Microcirc. 2004;31:149–156
  25. Woodward M, Rumley A, Lowe GD, Tunstall-Pedoe H. C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol. 2003;122:135–141

PII: S0167-5273(06)00150-1

doi: 10.1016/j.ijcard.2005.11.104

International Journal of Cardiology
Volume 112, Issue 2 , Pages 229-233 , 20 September 2006

Article Tools

* Image Usage & Resolution